LEKPHARM QUALITY IS AFFORDABLE! LEKPHARM is a full circle - - PowerPoint PPT Presentation

lekpharm quality is affordable
SMART_READER_LITE
LIVE PREVIEW

LEKPHARM QUALITY IS AFFORDABLE! LEKPHARM is a full circle - - PowerPoint PPT Presentation

LEKPHARM QUALITY IS AFFORDABLE! LEKPHARM is a full circle manufacturing pharmaceutical company that operates according to GMP standarts Developing Studies Registration Manufacturing Quality control Distribution


slide-1
SLIDE 1

LEKPHARM QUALITY IS AFFORDABLE!

slide-2
SLIDE 2

LEKPHARM is a full circle manufacturing pharmaceutical company that operates according to GMP standarts  Developing  Studies  Registration  Manufacturing  Quality control  Distribution

slide-3
SLIDE 3

In 2006 «Lekpharm» received license to perform pharmaceutical activities

History

slide-4
SLIDE 4

2007 – GMP certificate for tablets manufacturing

History

slide-5
SLIDE 5

2010 – renewal of GMP certificate for manufacturing tablets 2013 – renewal of GMP certificate for manufacturing tablets

History

slide-6
SLIDE 6

2014 – international GMP certificate that complies Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S)

History

slide-7
SLIDE 7

2015 – GMP certificate for manufacturing powders in sachet bags

History

slide-8
SLIDE 8

2015 – GMP certificate for manufacturing sterile injections in ampoules

History

slide-9
SLIDE 9

2011 – ISO 14001 certificate 2014 – ISO 14001 certificate renewal

History

slide-10
SLIDE 10

2006 – laboratory accreditation under ISO 17025 2009, 2014 – ISO 17025 accreditation renewal

История

slide-11
SLIDE 11

«Best enterpreneur of Republic of Belarus» in medical field – 2009, 2010, 2011 Decree of the President of Republic of Belarus №296 от 01.07.2014 Lekpharm became a member of State Honor Board «Best export company of 2014» in medical field

Awards

slide-12
SLIDE 12

Manufacturing

Cardiological medicines Medicines for treatment:

Musculoskeletal system GIT General anesthesia Antiviral, symptomatic Mineral-vitamin complexes

Forms: tablets capsules powders in sachets ampoules

slide-13
SLIDE 13

Quality

Main priority – guarantee the expected level and stability of the quality of products, its safety and efficiency.

slide-14
SLIDE 14

Russia India China Austria Czech Rep Great Britain Latin America Germany Denmark Croatia Spain

Careful selection of supply partners

Lekpharm – quality is affordable!

slide-15
SLIDE 15

Automatic control of production process parameters Control over the proper operation of the equipment is carried out by highly qualified personnel

Manufacturing

slide-16
SLIDE 16

Equipment

Tablets Capsules Sachet bags Ampoules Laboratory Contract Manufacturing

slide-17
SLIDE 17

The production capacity of the enterprise is 1 billion units per year for all forms combined

Capacity

slide-18
SLIDE 18

Manufacturing building

Total area of the premises – 5582,9 m² Manufacturing area – 793,2 m² Warehouse area – 1600,6 m² Quality control department – 322,7 m² Chemical laboratory - 185,6 m² Microbiological laboratory - 137,1 m²

slide-19
SLIDE 19

Departments:

  • Quality assesment – 5
  • Quality control – 49
  • Validation – 4
  • Mechanics – 12
  • Manufacturing – 111
  • Research and Development – 21
  • Warehouse – 7
  • Distibution – 31
  • Administration - 81

325 employees

slide-20
SLIDE 20

Key financial data 2016

Manufactured: 49,950 mln USD, growth rate 126,6%

Supplied:

41,526 mln USD, growth rate 131,6%

Exported:

5,653 mln USD

slide-21
SLIDE 21

№ Company 2016 year Volume sales sum, USD

1 Belmedpreparaty 82 652 217 2 Borisovskiy Zavod Medicinskikh Preparatov 61 400 141 3 Lekpharm 42 856 058 4 NOVARTIS 29 208 750 5 Pharmland Group 25 669 972 6 SANOFI 25 540 888 7 TAKEDA 22 356 876 8 PHARMTECHNOLOGY 21 942 863 9 GEDEON RIHTER 20 778 128 10 GSK 20 592 574

Lekpharm — one of the leading enterprises in Belarus

slide-22
SLIDE 22

Quality control studies: 2013 year – 81959, 2014 year – 96629, 2015 year – 126565, 2016 year – 137 748

Annual report

Dosage form Produced 2013 year Produced 2014 year Produced 2015 year Produced 2016 year mln. units Growth rate % mln. units Growth rate % mln. units Growth rate % mln. units Growth rate % Tablets

473,1 119 546,4 115,5 606,3 130,0 519,9 85,7

Capsules

75,3 106 96,2 127,8 143,2 149,2 61,8 43,2

Sachet

5,5 440 8,7 157,9 14,9 171,3 12,1 6,7

Ampoules

  • 0,2
  • 1,9

950

slide-23
SLIDE 23

The list of medicines

57 INN 11 INN

2007 2016

AMBROXOL ALFAHOLIN (choline alfoscerate) HYDROCHLOROTHIAZ IDE CLOPIDOGREL LF MOXONIDIN LF TAMSULOSIN LF AMLODIPINE AMBROXOL GLICLAZID MV LEVOCETIRIZIN LF MOLSIDOMIN LF TRI-ZIDIN M (trimetazidine) ARPETOL (umifenovir) AMPLODIPINE GRIPOMIX LIZITAR LF NEIROVIT FENSPIRID LF VIASIL (sildenafil) AMLOTESIN (perindopril/amlodip ine) DEZLORATADIN LF LIPROMAK LF (ATORVASTATIN) NISIT (nimesulide) FIGURIN (orlistat) VINNER LF (vinpocetine) ARPETOL DEXKETOPROFEN LF LOVASTATIN NITROGLYCERIN CHLOROPYRAMIN LF DROTAVERINE ASC DROTAVERINE MAGNELEK NIFUROXAZID LF HONDROMED (chondroitin sulfate) NITROGLYCERIN BETAHISTINUM INDALONG (indapamide) MEBEVERIN LF NITCERGOLIN LF HONDROMED PLUS (chondroitin sulfate+glucosamin) OMEPRAZOLE BICARD-LF (bisoprolol) INDATENSIN (perindopril/indapamid e) MEKSILEK OMEPRAZOLE CERALIN (citicoline) HONDROMED (chondroitin sulfate) VIASIL (sildenafil) INTRACONAZOL MELOXICAM LF ORVIKOLD EKVAPRIL ENALAPRIL VINNER LF (vinpocetine) KETONOF LF MELDONAT PERINDOPRIL LF ESFOLIP ABC of Health HEPATOLEK KETOPROFEN LF METOPROLOL RAMILONG (ramipril) RAMILONG PLUS

(ramipril+hydrochlorothia zide)

slide-24
SLIDE 24

We export in 7 countries | 28 Distributors | 87 foreign product registrations | Representative offices in Moldova, Kazakhstan Lithuania Moldova Georgia Azerbaijan Ukraine Russia Vietnam Kazakhstan Kyrgyzstan Uzbekistan

slide-25
SLIDE 25

Expanding capacities in 2016

June 2015 Lekpharm started manufacturing of sterile injections in ampoules Innovative equipment and modern technology allow to reach capacity of 150 mln ampoules per year

slide-26
SLIDE 26

Plans for 2017

In 2017 Lekpharm is going to modernize and increase capacity of manufacturing solid drug forms in tablets, capsules and powders

slide-27
SLIDE 27

R&D of generics in 2017

R&D - 22 generics at BE stage – 10 medicines in the registration process – 7 medecines in the registration process abroad – 29 medicines in 2017-2018 R&D pipeline – more than 40 medicines

slide-28
SLIDE 28

LEKPHARM JLLC

Thank you for the attention!

Belarus Logoisk, 2A Minskaya str. T: +375 25 606 90 12 email:

  • ffice@Lekpharm.by

marchenko@Lekpharm.by

  • stapchik@lekpharm.by